Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects

被引:46
|
作者
Rey, Federica [1 ,2 ]
Ottolenghi, Sara [3 ]
Zuccotti, Gian Vincenzo [1 ,2 ,4 ]
Samaja, Michele [3 ]
Carelli, Stephana [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy
[2] Univ Milan, Paediat Clin Res Ctr Fdn Romeo & Enrica Invernizz, Milan, Italy
[3] Univ Milan, Dept Hlth Sci, Lab Biochem, Milan, Italy
[4] Childrens Hosp V Buzzi, Dept Paediat, Milan, Italy
关键词
Alzheimer's disease; amyotrophic lateral sclerosis; mitochondria; mitochondria modulation; mitochondrial dysfunction; mitochondrial health; Mitostress; Mitotracker; neurodegenerative disease; Parkinson's disease; ALZHEIMERS-DISEASE; MUTATIONS; PARKINSONISM;
D O I
10.4103/1673-5374.322430
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fundamental organelles that occur in every cell type with the exception of mammal erythrocytes, the mitochondria are required for multiple pivotal processes that include the production of biological energy, the biosynthesis of reactive oxygen species, the control of calcium homeostasis, and the triggering of cell death. The disruption of anyone of these processes has been shown to impact strongly the function of all cells, but especially of neurons. In this review, we discuss the role of the mitochondria impairment in the development of the neurodegenerative diseases Amyotrophic Lateral Sclerosis, Parkinson's disease and Alzheimer's disease. We highlight how mitochondria disruption revolves around the processes that underlie the mitochondria's life cycle: fusion, fission, production of reactive oxygen species and energy failure. Both genetic and sporadic forms of neurodegenerative diseases are unavoidably accompanied with and often caused by the dysfunction in one or more of the key mitochondrial processes. Therefore, in order to get in depth insights into their health status in neurodegenerative diseases, we need to focus into innovative strategies aimed at characterizing the various mitochondria! processes. Current techniques include Mitostress, Mitotracker, transmission electron microscopy, oxidative stress assays along with expression measurement of the proteins that maintain the mitochondrial health. We will also discuss a panel of approaches aimed at mitigating the mitochondria! dysfunction. These include canonical drugs, natural compounds, supplements, lifestyle interventions and innovative approaches as mitochondria transplantation and gene therapy. In conclusion, because mitochondria are fundamental organelles necessary for virtually all the cell functions and are severely impaired in neurodegenerative diseases, it is critical to develop novel methods to measure the mitochondrial state, and novel therapeutic strategies aimed at improving their health.
引用
收藏
页码:754 / 758
页数:5
相关论文
共 50 条
  • [31] Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases
    Xu, Mengying
    Li, Tianjiao
    Liu, Xuan
    Islam, Binish
    Xiang, Yuyue
    Zou, Xiyan
    Wang, Jianwu
    NEUROCHEMICAL RESEARCH, 2025, 50 (01)
  • [32] The Emerging Role of Autophagy-Associated lncRNAs in the Pathogenesis of Neurodegenerative Diseases
    Jiang, Yapei
    Xu, Naihan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [33] The role of gut microbiota in the pathogenesis of neuropsychiatric and neurodegenerative diseases
    Szewczyk, Aleksandra
    Witecka, Apolonia
    Kiersztan, Anna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 865 - 886
  • [34] Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
    Zheng, Huiyong
    Liu, Qiang
    Zhou, Siwei
    Luo, Hongliang
    Zhang, Wenjun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies
    Moradi Vastegani, Sadegh
    Nasrolahi, Ava
    Ghaderi, Shahab
    Belali, Rafie
    Rashno, Masome
    Farzaneh, Maryam
    Khoshnam, Seyed Esmaeil
    NEUROCHEMICAL RESEARCH, 2023, 48 (08) : 2285 - 2308
  • [36] Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
    Sadegh Moradi Vastegani
    Ava Nasrolahi
    Shahab Ghaderi
    Rafie Belali
    Masome Rashno
    Maryam Farzaneh
    Seyed Esmaeil Khoshnam
    Neurochemical Research, 2023, 48 : 2285 - 2308
  • [37] A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
    Suzen, Sibel
    Tucci, Paolo
    Profumo, Elisabetta
    Buttari, Brigitta
    Saso, Luciano
    PHARMACEUTICALS, 2022, 15 (06)
  • [38] The Role of α-Synuclein in Neurodegenerative Diseases: From Molecular Pathways in Disease to Therapeutic Approaches
    Al-Mansoori, Karima M.
    Hasan, Mohamed Y.
    Al-Hayani, Abdulmonem
    El-Agnaf, Omar M. A.
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (06) : 559 - 568
  • [39] Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases
    Swerdlow, Russell H.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (31) : 3356 - 3373
  • [40] Prospects for therapeutic vaccination with glatiramer acetate for neurodegenerative diseases such as Alzheimer's disease
    Schwartz, M
    Kipnis, J
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (02) : 143 - 149